186 related articles for article (PubMed ID: 16935935)
1. Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARalpha.
Wang JG; Barsky LW; Davicioni E; Weinberg KI; Triche TJ; Zhang XK; Wu L
FASEB J; 2006 Oct; 20(12):2142-4. PubMed ID: 16935935
[TBL] [Abstract][Full Text] [Related]
2. Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha.
Wang J; Barsky LW; Shum CH; Jong A; Weinberg KI; Collins SJ; Triche TJ; Wu L
J Biol Chem; 2002 Nov; 277(45):43369-76. PubMed ID: 12213824
[TBL] [Abstract][Full Text] [Related]
3. Activation of
Zhang F; Zhu YL; Deng WL; Zhu J; Zhang J
J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
[TBL] [Abstract][Full Text] [Related]
4. Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/Rarα Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: in Vitro and in Vivo Studies.
Wu D; Shao K; Zhou Q; Sun J; Wang Z; Yan F; Liu T; Wu X; Ye B; Huang H; Zhou Y
Cell Physiol Biochem; 2018; 48(6):2286-2301. PubMed ID: 30114705
[TBL] [Abstract][Full Text] [Related]
5. Retinoid-modulated MAT1 ubiquitination and CAK activity.
He Q; Peng H; Collins SJ; Triche TJ; Wu L
FASEB J; 2004 Nov; 18(14):1734-6. PubMed ID: 15345685
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells.
Luo P; Wang A; Payne KJ; Peng H; Wang JG; Parrish YK; Rogerio JW; Triche TJ; He Q; Wu L
Stem Cells; 2007 Oct; 25(10):2628-37. PubMed ID: 17628022
[TBL] [Abstract][Full Text] [Related]
7. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
Jing Y
Leuk Lymphoma; 2004 Apr; 45(4):639-48. PubMed ID: 15160934
[TBL] [Abstract][Full Text] [Related]
8. Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation.
Wang A; Alimova IN; Luo P; Jong A; Triche TJ; Wu L
FASEB J; 2010 Mar; 24(3):833-43. PubMed ID: 19917671
[TBL] [Abstract][Full Text] [Related]
9. MAT1-modulated cyclin-dependent kinase-activating kinase activity cross-regulates neuroblastoma cell G1 arrest and neurite outgrowth.
Zhang S; He Q; Peng H; Tedeschi-Blok N; Triche TJ; Wu L
Cancer Res; 2004 May; 64(9):2977-83. PubMed ID: 15126328
[TBL] [Abstract][Full Text] [Related]
10. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
11. The clinically relevant CHK1 inhibitor MK-8776 induces the degradation of the oncogenic protein PML-RARα and overcomes ATRA resistance in acute promyelocytic leukemia cells.
Franza M; Albanesi J; Mancini B; Pennisi R; Leone S; Acconcia F; Bianchi F; di Masi A
Biochem Pharmacol; 2023 Aug; 214():115675. PubMed ID: 37406967
[TBL] [Abstract][Full Text] [Related]
12. UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia.
Kitareewan S; Pitha-Rowe I; Sekula D; Lowrey CH; Nemeth MJ; Golub TR; Freemantle SJ; Dmitrovsky E
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3806-11. PubMed ID: 11891284
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia.
Guo Y; Dolinko AV; Chinyengetere F; Stanton B; Bomberger JM; Demidenko E; Zhou DC; Gallagher R; Ma T; Galimberti F; Liu X; Sekula D; Freemantle S; Dmitrovsky E
Cancer Res; 2010 Dec; 70(23):9875-85. PubMed ID: 20935222
[TBL] [Abstract][Full Text] [Related]
14. Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα.
Dai B; Wang F; Wang Y; Zhu J; Li Y; Zhang T; Zhao L; Wang L; Gao W; Li J; Zhu H; Li K; Hu J
Cell Death Differ; 2023 May; 30(5):1320-1333. PubMed ID: 36894687
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repression of CDKN2D by PML/RARα contributes to the altered proliferation and differentiation block of acute promyelocytic leukemia cells.
Wang Y; Jin W; Jia X; Luo R; Tan Y; Zhu X; Yang X; Wang X; Wang K
Cell Death Dis; 2014 Oct; 5(10):e1431. PubMed ID: 25275592
[TBL] [Abstract][Full Text] [Related]
16. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
[TBL] [Abstract][Full Text] [Related]
17. Repression of CDKN2C caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia.
Wang X; Tan Y; Li Y; Li J; Jin W; Wang K
Front Med; 2016 Dec; 10(4):420-429. PubMed ID: 27888400
[TBL] [Abstract][Full Text] [Related]
18. A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest.
Casini T; Pelicci PG
Oncogene; 1999 May; 18(21):3235-43. PubMed ID: 10359529
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation.
Rashid A; Wang R; Zhang L; Yue J; Yang M; Yen A
Exp Cell Res; 2020 Sep; 394(1):111989. PubMed ID: 32283065
[TBL] [Abstract][Full Text] [Related]
20. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein.
Nervi C; Ferrara FF; Fanelli M; Rippo MR; Tomassini B; Ferrucci PF; Ruthardt M; Gelmetti V; Gambacorti-Passerini C; Diverio D; Grignani F; Pelicci PG; Testi R
Blood; 1998 Oct; 92(7):2244-51. PubMed ID: 9746761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
